Zonare Medical Systems raised $34 million in equity funding earlier this month to put toward the development of a next-generation ultrasound platform. The company's Zone Sonography technology is being groomed first for general imaging and ob/gyn.
Zonare Medical Systems raised $34 million in equity funding earlier this month to put toward the development of a next-generation ultrasound platform. The company's Zone Sonography technology is being groomed first for general imaging and ob/gyn. Subsequent developments will address cardiology and 4D imaging. Previous and new investors include Montagu Newhall Associates, Kaiser Permanente Ventures, Earlybird Venture Capital, and Siemens Venture Capital.
The company is being directed by new president and CEO Donald J. Southard, who joined the firm last month after serving as president of Datascope's $160 million patient monitoring business.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.